Saporin Conjugated Monoclonal Antibody to the Transcobalamin Receptor TCblR/CD320 Is Effective in Targeting and Destroying Cancer Cells

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Saporin Conjugated Monoclonal Antibody to the Transcobalamin Receptor TCblR/CD320 Is Effective in Targeting and Destroying Cancer Cells"
written by Edward V. Quadros, Yasumi Nakayama, Jeffrey M. Sequeira,
published by Journal of Cancer Therapy, Vol.4 No.6, 2013

has been cited by the following article(s):

[1]	Identification of a novel mechanism for meso‐tetra (4‐carboxyphenyl) porphyrin (TCPP) uptake in cancer cells
	2021

[2]	Generation of nanobodies targeting the human, transcobalamin-mediated vitamin B12 uptake route
	bioRxiv, 2021

[3]	Cellular uptake of vitamin B12: Role and fate of TCblR/CD320, the transcobalamin receptor
	2020

[4]	Vitamin-B12-conjugated sericin micelles for targeting CD320-overexpressed gastric cancer and reversing drug resistance
	2018

[5]	Vitamin-B12-Conjugated Sericin Micelles for Targeting Gastric Cancer and Reversing Drug Resistance
	2018

[6]	Developing protein conjugation techniques to enhance cell delivery of therapeutic enzymes
	2017

[7]	CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma
	Oncotarget, 2017

[8]	Structural basis of transcobalamin recognition by human CD320 receptor
	Nature Communications, 2016

[9]	L'interactome de la méthionine synthase
	Thèse, 2016

[10]	Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy
	Current pharmaceutical design, 2014

[1]	Generation of nanobodies targeting the human, transcobalamin‐mediated vitamin B 12 uptake route The FASEB Journal, 2022 DOI:10.1096/fj.202101376RR

[2]	Generation of nanobodies targeting the human, transcobalamin‐mediated vitamin B 12 uptake route The FASEB Journal, 2022 DOI:10.1096/fj.202101376RR

[3]	Identification of a novel mechanism for meso‐tetra (4‐carboxyphenyl) porphyrin (TCPP) uptake in cancer cells The FASEB Journal, 2021 DOI:10.1096/fj.202000197R

[4]	Cellular uptake of vitamin B12: Role and fate of TCblR/CD320, the transcobalamin receptor Experimental Cell Research, 2020 DOI:10.1016/j.yexcr.2020.112256

[5]	Vitamin B12-conjugated sericin micelles for targeting CD320-overexpressed gastric cancer and reversing drug resistance Nanomedicine, 2019 DOI:10.2217/nnm-2018-0321

[6]	CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma Oncotarget, 2017 DOI:10.18632/oncotarget.22131

[7]	Structural basis of transcobalamin recognition by human CD320 receptor Nature Communications, 2016 DOI:10.1038/ncomms12100

[8]	Structural basis of transcobalamin recognition by human CD320 receptor Nature Communications, 2016 DOI:10.1038/ncomms12100

Follow SCIRP